Spasticity Treatments

Find Spasticity Treatments

Generic Name

TiZANidine

Brand Names

Tizanidne, Ontralfy, Zanaflex, Tizandine

FDA approval date: July 03, 2002

Classification: Central alpha-2 Adrenergic Agonist

Form: Tablet, Capsule, Solution

What is Tizanidne (TiZANidine)?

TizanidineTablets, USP is a central alpha-2-adrenergic agonist indicated for themanagement of spasticity. Because of the short duration of therapeutic effect,treatment with Tizanidine Tablets, USP should be reserved for those dailyactivities and times when relief of spasticity is most important [ see Dosage andAdministration.

Approved To Treat

Spasticity

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures

Enrollment Status: Recruiting

Publish Date: April 13, 2026

Intervention Type: Drug

Study Phase: Phase 4

Objective: To measure postoperative pain control in patients in two treatment arms of ORIF of the clavicle: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen. Study

Effect of CYP2B6 Genotype and Efavirenz on the Disposition and Pharmacodynamic of Methadone and Tizanidine in Healthy Volunteers

Enrollment Status: Recruiting

Publish Date: February 12, 2026

Intervention Type: Drug

Study Phase: Early Phase 1

Summary: The main goal of this clinical study is to test how CYP2B6 genetic variations and efavirenz (cornerstone in HIV-1 therapy) dictate the disposition (PK) of CYP2B6 substrate (methadone) and PK and effect (PD) of CYP1A2 substrate (tizanidine). Specifically, the investigators will test whether efavirenz produces CYP2B6 genotype dependent unanticipated DDIs with CYP2B6 (methadone) and CYP1A2 (tizanidin...

The Effects of Tizanidine on Acoustic Reflex

Enrollment Status: Recruiting

Publish Date: December 30, 2025

Intervention Type: Drug

Study Phase: Not Applicable

Summary: The goal of this clinical trial is to learn how the muscle relaxant tizanidine affects the acoustic reflex in adults. The acoustic reflex is a natural protection system of the ear that helps reduce the impact of loud sounds. It is not known whether tizanidine changes how this reflex works. The main question this study aims to answer is: Does taking tizanidine for 1 week change acoustic reflex thre...

View All Clinical Trials